BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
Manipal Hospitals Buys 87% Stake in Kolkata’s Medica Synergie April 30, 2024 With the addition of Medica, Manipal Hospitals will have expanded presence across 14 states via 37 facilities. Its total bed count will increase to over 10,500 beds.
Eli Lilly Inks Deal to Acquire Nexus Manufacturing Plant Amid Drug Shortages April 26, 2024 The move comes at a critical time as shortages of Mounjaro, a widely-used diabetes therapy, and Zepbound, its obesity counterpart, continue to impact patients across the United States.
Mumbai’s Zeno Health Acquires Tablt Pharmacy to Enter Eastern Market April 5, 2024 Established in 2017 by IIT Bombay alumni Siddharth Gadia and Girish Agarwal, Zeno Health has become the primary destination for generic medicines in the region.
Eris Lifesciences Acquires Biocon Biologics’ India Branded Formulation Biz for INR 1,242 Cr March 18, 2024 This strategic move aims to expand Eris's presence in the Indian market and venture into the lucrative injectables segment, valued at over INR 30,000 Cr.
Sun Pharma to Acquire 16.33% Stake of Surgimatix for $3.05 Mn February 21, 2024 Per the deal, Sun Pharma will have the option to receive warrants equivalent to 20% of the shares purchased, exercisable at $4.867 per share.
Max Healthcare Acquires Alexis Hospital for INR 412 Cr to Expand Presence in Maharashtra February 12, 2024 The acquisition marks a strategic move by Max Healthcare to bolster its presence in Tier-II cities with robust healthcare infrastructure and a wealth of clinical talent.
Sun Pharma Acquires Israel’s Taro Pharma in a Deal Worth $347.73 Mn January 19, 2024 This merger comes after almost 17 years of negotiations and discussions. Additionally, the deal is expected to close in the first half of 2024.
Dr Reddy's Acquires 6.5% Stake in Israeli Biotech Company Edity January 2, 2024 Reportedly, the Hyderabad-based pharma has picked up 10,14,442 preferred A-1 shares, equivalent to 6.46% of Israel-based Edity's share capital on a fully diluted basis, for $1.9715 per share, by way of conversion of SAFE.
Bristol Myers to Acquire RayzeBio in a $4.1 Bn Deal December 28, 2023 This acquisition seeks to establish Bristol’s presence in one of the most promising and fastest-growing new modalities for the treatment of patients with solid tumours, delivering radioactive payloads to cancer cells in a targeted manner.
Sterling Accuris Diagnostics Expands Portfolio with Acquisition of Vaibhav Analytical Services December 14, 2023 The acquisition, as shared by Rajiv Sharma, MD of Sterling Accuris Diagnostics in an official statement, aims to broaden the scope of services, particularly in pharmaceutical analytical testing.
AbbVie to Acquire Cerevel Therapeutics for $8.7 Bn to Boost Neurological Drug Portfolio December 11, 2023 Trading in options for Cerevel experienced an unusual surge in the days leading up to the announcement, with significant interest in upside call options.
Syngene Acquires Biologics Manufacturing Facility from Stelis Biopharma December 4, 2023 The acquisition, known as 'Unit 3,' was finalised at a revised gross value of INR 617 Cr, following adjustments from the initially stated INR 702 Cr.
